Calbee, Inc.
Calbee, Inc. (CLBEY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Calbee, Inc. (CLBEY), covering cash flow, earnings, and balance sheets.
Calbee, Inc. (CLBEY) Income Statement & Financial Overview
Review Calbee, Inc. CLBEY income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $78.79B | $86.71B | $79.41B | $77.66B |
| Cost of Revenue | $53.95B | $55.57B | $52.59B | $50.61B |
| Gross Profit | $24.84B | $31.14B | $26.82B | $27.05B |
| Gross Profit Ratio | $0.32 | $0.36 | $0.34 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $21.04B | $20.82B | $19.58B | $19.37B |
| Operating Expenses | $21.04B | $20.82B | $19.58B | $17.77B |
| Total Costs & Expenses | $74.99B | $76.38B | $72.17B | $69.98B |
| Interest Income | $138.00M | $100.00M | $148.00M | $108.00M |
| Interest Expense | $92.00M | $90.00M | $89.00M | $87.00M |
| Depreciation & Amortization | $4.20B | $3.52B | $3.31B | $3.26B |
| EBITDA | $7.49B | $13.82B | $8.89B | $12.68B |
| EBITDA Ratio | $0.10 | $0.16 | $0.11 | $0.16 |
| Operating Income | $3.79B | $10.32B | $7.24B | $7.66B |
| Operating Income Ratio | $0.05 | $0.12 | $0.09 | $0.10 |
| Other Income/Expenses (Net) | -$721.00M | $1.19B | -$1.76B | $1.66B |
| Income Before Tax | $3.07B | $11.52B | $5.48B | $9.32B |
| Income Before Tax Ratio | $0.04 | $0.13 | $0.07 | $0.12 |
| Income Tax Expense | $488.00M | $3.75B | $1.79B | $1.86B |
| Net Income | $2.52B | $7.72B | $3.56B | $7.07B |
| Net Income Ratio | $0.03 | $0.09 | $0.04 | $0.09 |
| EPS | $20.19 | $61.78 | $28.51 | $56.62 |
| Diluted EPS | $20.19 | $61.78 | $28.51 | $56.62 |
| Weighted Avg Shares Outstanding | $124.94M | $124.94M | $124.94M | $124.88M |
| Weighted Avg Shares Outstanding (Diluted) | $124.94M | $124.94M | $124.94M | $124.88M |
Over the past four quarters, Calbee, Inc. demonstrated steady revenue growth, increasing from $77.66B in Q1 2024 to $78.79B in Q4 2024. Operating income reached $3.79B in Q4 2024, maintaining a consistent 5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $7.49B, reflecting operational efficiency. Net income dropped to $2.52B, with EPS at $20.19. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan